Navneet Majhail, MD of Cleveland Clinic, gives an overview of Abstract 69: Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation, which was presented at the 58th ASH Annual Meeting in San Diego, CA.
Genetic Alterations Predict Outcomes in MDS
